share_log

Wedbush Reiterates Neutral on Biogen, Maintains $263 Price Target

Benzinga ·  May 23, 2023 07:39

Wedbush analyst Laura Chico reiterates Biogen (NASDAQ:BIIB) with a Neutral and maintains $263 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment